Tianyin Pharmaceutical, Co. will add to its list of modernized traditional Chinese medicines the recently SFDA-approved Laonian Kechuan Tablets, a new drug for the company which was approved with a dose of 0.25 gram/tablet. The product is aimed at asthma sufferers who are 60 years old and above. Tianyin will begin recording revenue from the product in November 2008. More details...

Stock Symbol: (OTCBB: TYNP)